vs
Orthofix Medical Inc.（OFIX）与SUBURBAN PROPANE PARTNERS LP（SPH）财务数据对比。点击上方公司名可切换其他公司
SUBURBAN PROPANE PARTNERS LP的季度营收约是Orthofix Medical Inc.的1.7倍（$370.4M vs $219.9M），SUBURBAN PROPANE PARTNERS LP净利率更高（12.4% vs -1.0%，领先13.4%），Orthofix Medical Inc.同比增速更快（2.0% vs -0.8%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-67.5M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -13.8%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Suburban Propane Partners LP是美国领先的丙烷、天然气、取暖油及相关能源产品分销商，服务覆盖住宅、商业、工业、农业等各类客户，同时提供暖通空调系统的安装、维护与维修服务，业务范围遍布全美。
OFIX vs SPH — 直观对比
营收规模更大
SPH
是对方的1.7倍
$219.9M
营收增速更快
OFIX
高出2.8%
-0.8%
净利率更高
SPH
高出13.4%
-1.0%
自由现金流更多
OFIX
多$84.3M
$-67.5M
两年增速更快
OFIX
近两年复合增速
-13.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $370.4M |
| 净利润 | $-2.2M | $45.8M |
| 毛利率 | 71.1% | 64.7% |
| 营业利润率 | 0.2% | 18.3% |
| 净利率 | -1.0% | 12.4% |
| 营收同比 | 2.0% | -0.8% |
| 净利润同比 | 92.4% | 135.7% |
| 每股收益（稀释后） | $-0.05 | $0.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXSPH
| Q4 25 | $219.9M | $370.4M | ||
| Q3 25 | $205.6M | $211.4M | ||
| Q2 25 | $203.1M | $260.1M | ||
| Q1 25 | $193.6M | $587.7M | ||
| Q4 24 | $215.7M | $373.3M | ||
| Q3 24 | $196.6M | $208.6M | ||
| Q2 24 | $198.6M | $254.6M | ||
| Q1 24 | $188.6M | $498.1M |
净利润OFIXSPH
| Q4 25 | $-2.2M | $45.8M | ||
| Q3 25 | $-22.8M | $-35.1M | ||
| Q2 25 | $-14.1M | $-14.8M | ||
| Q1 25 | $-53.1M | $137.1M | ||
| Q4 24 | $-29.1M | $19.4M | ||
| Q3 24 | $-27.4M | $-44.6M | ||
| Q2 24 | $-33.4M | $-17.2M | ||
| Q1 24 | $-36.0M | $111.5M |
毛利率OFIXSPH
| Q4 25 | 71.1% | 64.7% | ||
| Q3 25 | 72.2% | 64.7% | ||
| Q2 25 | 68.7% | 61.7% | ||
| Q1 25 | 62.8% | 58.8% | ||
| Q4 24 | 69.0% | 60.6% | ||
| Q3 24 | 68.7% | 59.4% | ||
| Q2 24 | 67.8% | 62.9% | ||
| Q1 24 | 67.5% | 61.8% |
营业利润率OFIXSPH
| Q4 25 | 0.2% | 18.3% | ||
| Q3 25 | -8.3% | -7.9% | ||
| Q2 25 | -7.9% | 2.1% | ||
| Q1 25 | -25.2% | 27.0% | ||
| Q4 24 | -5.3% | 15.8% | ||
| Q3 24 | -9.6% | -10.8% | ||
| Q2 24 | -12.5% | 3.2% | ||
| Q1 24 | -15.6% | 27.5% |
净利率OFIXSPH
| Q4 25 | -1.0% | 12.4% | ||
| Q3 25 | -11.1% | -16.6% | ||
| Q2 25 | -6.9% | -5.7% | ||
| Q1 25 | -27.4% | 23.3% | ||
| Q4 24 | -13.5% | 5.2% | ||
| Q3 24 | -13.9% | -21.4% | ||
| Q2 24 | -16.8% | -6.8% | ||
| Q1 24 | -19.1% | 22.4% |
每股收益（稀释后）OFIXSPH
| Q4 25 | $-0.05 | $0.69 | ||
| Q3 25 | $-0.57 | $-0.55 | ||
| Q2 25 | $-0.36 | $-0.23 | ||
| Q1 25 | $-1.35 | $2.10 | ||
| Q4 24 | $-0.76 | $0.30 | ||
| Q3 24 | $-0.71 | $-0.69 | ||
| Q2 24 | $-0.88 | $-0.27 | ||
| Q1 24 | $-0.95 | $1.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $1.3M |
| 总债务越低越好 | — | $1.3B |
| 股东权益账面价值 | $450.0M | — |
| 总资产 | $850.6M | $2.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXSPH
| Q4 25 | $82.0M | $1.3M | ||
| Q3 25 | $62.9M | $405.0K | ||
| Q2 25 | $65.6M | $1.3M | ||
| Q1 25 | $58.0M | $3.9M | ||
| Q4 24 | $83.2M | $4.4M | ||
| Q3 24 | $30.1M | $3.2M | ||
| Q2 24 | $26.4M | $4.9M | ||
| Q1 24 | $27.0M | $4.4M |
总债务OFIXSPH
| Q4 25 | — | $1.3B | ||
| Q3 25 | $157.2M | $1.2B | ||
| Q2 25 | $157.0M | $1.2B | ||
| Q1 25 | $156.9M | $1.3B | ||
| Q4 24 | $157.0M | $1.3B | ||
| Q3 24 | $118.5M | $1.2B | ||
| Q2 24 | $118.0M | $1.2B | ||
| Q1 24 | $118.2M | $1.2B |
股东权益OFIXSPH
| Q4 25 | $450.0M | — | ||
| Q3 25 | $442.5M | — | ||
| Q2 25 | $458.3M | — | ||
| Q1 25 | $458.3M | — | ||
| Q4 24 | $503.1M | — | ||
| Q3 24 | $525.9M | — | ||
| Q2 24 | $546.0M | — | ||
| Q1 24 | $570.3M | — |
总资产OFIXSPH
| Q4 25 | $850.6M | $2.4B | ||
| Q3 25 | $832.6M | $2.3B | ||
| Q2 25 | $837.2M | $2.3B | ||
| Q1 25 | $823.1M | $2.4B | ||
| Q4 24 | $893.3M | $2.4B | ||
| Q3 24 | $867.9M | $2.3B | ||
| Q2 24 | $882.0M | $2.3B | ||
| Q1 24 | $906.0M | $2.3B |
负债/权益比OFIXSPH
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-47.7M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-67.5M |
| 自由现金流率自由现金流/营收 | 7.6% | -18.2% |
| 资本支出强度资本支出/营收 | 4.9% | 5.3% |
| 现金转化率经营现金流/净利润 | — | -1.04× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $61.9M |
8季度趋势，按日历期对齐
经营现金流OFIXSPH
| Q4 25 | $27.7M | $-47.7M | ||
| Q3 25 | $12.4M | $41.8M | ||
| Q2 25 | $11.6M | $95.5M | ||
| Q1 25 | $-18.4M | $40.1M | ||
| Q4 24 | $23.7M | $8.8M | ||
| Q3 24 | $11.7M | $36.8M | ||
| Q2 24 | $9.0M | $61.4M | ||
| Q1 24 | $-18.6M | $75.1M |
自由现金流OFIXSPH
| Q4 25 | $16.8M | $-67.5M | ||
| Q3 25 | $2.5M | $27.7M | ||
| Q2 25 | $4.5M | $80.9M | ||
| Q1 25 | $-25.1M | $20.8M | ||
| Q4 24 | $15.2M | $-15.1M | ||
| Q3 24 | $6.3M | $17.7M | ||
| Q2 24 | $-360.0K | $46.8M | ||
| Q1 24 | $-29.1M | $60.6M |
自由现金流率OFIXSPH
| Q4 25 | 7.6% | -18.2% | ||
| Q3 25 | 1.2% | 13.1% | ||
| Q2 25 | 2.2% | 31.1% | ||
| Q1 25 | -13.0% | 3.5% | ||
| Q4 24 | 7.0% | -4.0% | ||
| Q3 24 | 3.2% | 8.5% | ||
| Q2 24 | -0.2% | 18.4% | ||
| Q1 24 | -15.4% | 12.2% |
资本支出强度OFIXSPH
| Q4 25 | 4.9% | 5.3% | ||
| Q3 25 | 4.8% | 6.7% | ||
| Q2 25 | 3.5% | 5.6% | ||
| Q1 25 | 3.5% | 3.3% | ||
| Q4 24 | 4.0% | 6.4% | ||
| Q3 24 | 2.7% | 9.1% | ||
| Q2 24 | 4.7% | 5.8% | ||
| Q1 24 | 5.6% | 2.9% |
现金转化率OFIXSPH
| Q4 25 | — | -1.04× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
SPH
| Propane | $326.4M | 88% |
| Other Sales Revenue Net | $19.9M | 5% |
| Fuel Oil And Refined Fuels | $18.2M | 5% |
| Natural Gas And Electricity | $5.9M | 2% |
| Wholesale | $4.1M | 1% |
